Xinafoate salt of a substituted 5oxazol-2-yl-quinoline compound

Details for Australian Patent Application No. 2007273007 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Ting, Pauline C.; Feng, Kung I.; Mao, Chen; Trzaska, Scott T.; Reeder, Michael R.; Lee, Joe F.; Filipov, Dimitar L.; Zhu, Man; Zarkadas, Dimitrios

Agent Griffith Hack

Pub. Number AU-B-2007273007

PCT Pub. Number WO2008/008327

Priority 60/830,057 11.07.06 US

Filing date 10 July 2007

Wipo publication date 17 January 2008

Acceptance publication date 1 November 2012

International Classifications

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/008327 Priority application(s): WO2008/008327

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

1 November 2012 Application Accepted

  Published as AU-B-2007273007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007273015-Configurations and methods for rich gas conditioning for NGL recovery

2007273001-Smart card terminal side data and management framework